Literature DB >> 31654587

Two-year study on the application of the Paris system for urinary cytology in a cancer centre.

Rafaela de Paula1, Andrea Oliveira1, Warley Nunes1, Graziele Bovolim1, Tabata Domingos1, Louise De Brot1, Stephania Bezerra1, Isabela Cunha2, Mariane Morini2, Mauro Saieg1,3.   

Abstract

INTRODUCTION: The Paris system for reporting urinary cytology (TPS) was published in order to provide clear cytomorphological criteria for urine cytology specimens, focusing on high-grade urothelial lesions. The aim of this study was to evaluate the impact of implementing TPS and to correlate with available concomitant histological samples, accessing overall sensitivity and specificity.
METHODS: A retrospective analysis of urine cytology reports from 2017 to 2018 using TPS was carried out, with histological correlation to concomitant samples (up to 3 months). Statistical analysis was performed with calculation of sensitivity and specificity, positive and negative predictive values and risk of malignancy (ROM) for all TPS categories.
RESULTS: A total of 1660 specimens were evaluated. Histological specimens were available for 611 (36.8%) cases. Urine cytology categorised by TPS had 2.4% non-diagnostic cases, 87.1% negative for high-grade urothelial carcinoma (HGUC), 4.6% atypical urothelial cells, 2.7% suspicious for HGUC, 2.7% HGUC and 0.5% cases of other malignancies. Sensitivity, specificity, negative predictive value and positive predictive value were 40.0%, 99.3%, 88.2% and 92.3%, respectively. ROM of each category was 0% for non-diagnostic, 11.1% for negative for HGUC, 32.4% for atypical, 64.9% for suspicious for HGUC and 87.9% for HGUC and other malignancies.
CONCLUSION: Our findings indicated that implementation of TPS provided a high specificity and predictive positive value for the detection of high-grade urothelial lesions, with proportionally increasing ROMs as categories progress from negative to positive.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Paris system; atypia; bladder washing; urine cytology; urothelial carcinoma

Mesh:

Year:  2020        PMID: 31654587     DOI: 10.1111/cyt.12780

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.

Authors:  Bantita Phruttinarakorn; Sirithep Plumworasawat; Jitchai Kayankarnnavee; Jirasit Lualon; Atcharaporn Pongtippan
Journal:  Acta Cytol       Date:  2022-01-07       Impact factor: 2.319

Review 2.  The Paris System for Reporting Urinary Cytology: A Meta-Analysis.

Authors:  Ilias P Nikas; Svenja Seide; Tanja Proctor; Zoi Kleinaki; Maria Kleinaki; Jordan P Reynolds
Journal:  J Pers Med       Date:  2022-01-27

3.  Accuracy of Paris 2016 System for Non-invasive Diagnosis Bladder Malignancy.

Authors:  Azadeh Rakhshan; Esmat Arvin; Sam Alahyari; Behrang Kazeminegad; Tahmineh Mollasharifi; Alireza Bagheri; Fereshteh Aliakbari; Seyed Jalil Hosseini; Mohammad Soleimani; Mahsa Ahadi; Elena Jamali; Afshin Moradi; Zahra Sadeghzadeh; Saleh Ghiasi; Malihe Nasiri; Farzad Allameh
Journal:  Iran J Pathol       Date:  2022-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.